Myovant Sciences Patents – Insights & Stats (Updated 2024)

Myovant Sciences has a total of 86 patents globally, out of which 33 have been granted. Of these 86 patents, more than 91% patents are active. Japan is where Myovant Sciences has filed the maximum number of patents, followed by Europe (EPO) and Australia. Parallelly, the United States of America seems to be the main focused R&D centre and also is the origin country of Myovant Sciences.

Myovant Sciences was founded in 2016. Myovant Sciences is a company that works on developing treatments for women’s health issues and hormonal disorders. They’re currently working on a drug called relugolix to help with heavy menstrual bleeding from uterine fibroids and pain associated with endometriosis.

Do read about some of the most popular patents of Myovant Sciences which have been covered by us in this article and also you can find Myovant Sciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Myovant Sciences patent portfolio.

How many patents does Myovant Sciences have?

Myovant Sciences has a total of 86 patents globally. These patents belong to 8 unique patent families. Out of 86 patents, 79 patents are active.

How Many Patents did Myovant Sciences File Every Year?

Myovant Sciences Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantMyovant Sciences Applications FiledMyovant Sciences Patents Granted
202335
2022826
2021161
20208
201951
201746

How many Myovant Sciences patents are Alive/Dead?

Worldwide Patents

Myovant Sciences Patents Portfolio

How Many Patents did Myovant Sciences File in Different Countries?

Myovant Sciences Worldwide Patents

Countries in which Myovant Sciences Filed Patents

CountryPatents
Japan9
Europe (EPO)8
Australia7
Eurasian Patent Organization5
Canada4
Mexico4
Argentina4
New Zealand3
Brazil3
Taiwan2
South Africa2
Hong Kong (S.A.R.)2
Ecuador1
Republic of Moldova1
Poland1
Austria1
Slovakia1
Germany1
Paraguay 1
Denmark1
Hungary1
Norway1
Israel1
Peru1
Italy1
Portugal1
Chile1
Serbia1
Colombia1
Slovenia1
Lithuania1
Spain1
Malta1
Uruguay1
Croatia1
Morocco1
Korea (South)1

Where are Research Centers of Myovant Sciences Patents Located?

Research Centers of Myovant Sciences Patents

What are Myovant Sciences key innovation segments?

What Technologies are Covered by Myovant Sciences?

The chart below distributes patents filed by Myovant Sciences in different countries on the basis of the technology protected in patents. It also represents the markets where Myovant Sciences thinks it’s important to protect particular technology inventions.

R&D Focus: How has Myovant Sciences search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Myovant Sciences?

Related Articles

VoxelSensors Patents – Insights & Stats (Updated 2024)

VoxelSensors has a total of 36 patents globally, out of which 8 have been granted. Of these 36 patents, more than 94% patents are active. Europe (EPO) is where VoxelSensors has filed the maximum number of patents, followed by China and Israel. Parallelly, Belgium seems to be the main focused

Read More »

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.